Search results
The CDC Took Out 148 Pages of Essential Information
Mercola· 2 days agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of the outer lining of the heart. The public ...
Cancer trends revealed, including most common types of the disease and biggest risk factors
Fox News· 6 days agoOf the 1.96 million new cancer cases in 2023, half were made up of five types: breast cancer (15%),...
Apodaca: The nation's grade schools face one problem above all others
Los Angeles Times· 3 days agoIn-person learning is crucial to student development, but chronic absenteeism remains stubbornly...
Special education students still struggling with pandemic's setbacks
Newsday· 15 hours ago"She was totally out of sync," said Clark, adding that even after Brianna returned to school in the...
Foolishness and faux pas: The 2024 Niceley Awards
Tennessee Lookout via Yahoo News· 3 days agoEach legislative session, we can count on state lawmakers to pass a host of unnecessary and sometimes harmful legislation — with beneficial measures...
REUTERS NEWS SCHEDULE AT 10:00 a.m. GMT/ 6:00 a.m. ET
Reuters via Yahoo Finance· 4 days agoInvestors will closely watch any changes to the drugmaker's 2024 forecast, especially for COVID-19 vaccine and antiviral treatment Paxlovid. Fcus will also be on the performance ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
These Stocks Are Moving the Most Today: Carvana, Fastly, Peloton, Wayfair, Qualcomm, Moderna,...
Barrons.com· 2 days agoCarvana posts a surprise first-quarter profit, Fastly stock sinks after the company issues guidance...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 4 days agoThe company affirmed its full-year 2024 guidance of $58.5 billion to $61.5 billion in sales and...
Earnings call: Daiichi Sankyo posts strong FY 2023 results, plans growth
Investing.com· 6 days agoThe pharmaceutical company's strong performance was primarily driven by robust sales of its key...
